Peptides for Acne-Prone Skin: What Antimicrobial and Cosmetic Peptides Can (and Can't) Do

Can peptides help acne? We explain the antimicrobial peptides your skin makes, the peptide acne trials (including one that never published results), copper peptides for acne scars, and how to build a peptide routine around proven acne treatments.

By the Glow Cosmetics Editorial Team. Updated 2026-10-09.

"Are peptides good for acne?" is a fast-growing search, and peptide serums are increasingly marketed to breakout-prone skin. Here's an honest look at what peptides can and can't do, and how to use them alongside treatments that are proven to work.

Important: Acne is a medical skin condition. In the U.S., products that claim to treat acne are regulated as over-the-counter drugs and must use specific active ingredients (benzoyl peroxide, salicylic acid, sulfur, or resorcinol with sulfur) (21 CFR 333.310). Cosmetic peptide products, including ours, are not acne treatments. For moderate, severe, painful or scarring acne, see a board-certified dermatologist.

What causes acne?

Acne develops in the hair follicle and its oil gland. Four main factors work together (Moradi Tuchayi et al., 2015):

1. Excess oil (sebum), often driven by hormones.
2. Clogged follicles from sticky skin cells (follicular hyperkeratinization).
3. Cutibacterium acnes (formerly Propionibacterium acnes), a skin bacterium that thrives in clogged, oily follicles.
4. Inflammation, which turns clogged pores into red, painful spots.

What actually treats acne

The 2024 American Academy of Dermatology guideline reviewed the evidence and made these recommendations (Reynolds et al., 2024):

A Cochrane review of 49 trials found azelaic acid performs similarly to tretinoin in global assessment, though much of the evidence for these milder ingredients is low quality (Liu et al., 2020).

Your skin's own antimicrobial peptides

Your skin naturally makes antimicrobial peptides (AMPs), small defense molecules such as LL-37 (cathelicidin) and the β-defensins. In acne, they're clearly involved:

• hBD-2 is markedly increased in acne lesions, especially pustules (Chronnell et al., 2001).
• Some strains of C. acnes trigger skin cells to make hBD-2 and the inflammatory signal IL-8 (Nagy et al., 2005).
• AMP levels differ between lesion types: comedones, papules, pustules and nodules (Ozlu et al., 2016).

A 2024 review calls elevated AMPs "a hallmark" of acne and suggests they may be a compensatory response to an impaired skin barrier (Lesiak et al., 2024). Earlier experts described their role as "still emerging" (Harder et al., 2013). In short, AMPs are part of acne biology, but whether they help, hurt or both is unresolved.

Antimicrobial peptides as acne treatments: not there yet

Because bacteria are less likely to resist them than antibiotics, synthetic AMPs have been explored as acne treatments. The results so far:

• Omiganan: a synthetic AMP gel was tested in a Phase 2, double-blind, vehicle-controlled acne trial of 320 women that completed in 2016, but no results have been posted or published (ClinicalTrials.gov NCT02571998). The same gel's two rosacea trials split: one showed no difference from vehicle (NCT02576860) and one showed a modest benefit (NCT02547441).
• Granulysin-derived peptide: in an uncontrolled 12-week study of 30 people, pustules and acne scores fell, but comedones increased (Lim et al., 2015).
• Designed AMPs (e.g., RP556): effective against antibiotic-resistant C. acnes in lab and mouse studies only (Woodburn et al., 2020).

Bottom line: AMP-based acne treatments are an interesting research area, but there's no published proof they work in people. Be wary of products that claim an "antimicrobial peptide" kills acne bacteria.

Cosmetic peptides for acne-prone skin

A few small studies have tested peptides in acne-prone skin:

• An "autophagy-activating" peptide: in an 8-week, double-blind, vehicle-controlled trial, it reduced closed comedones, skin-surface oil and water loss (Lee et al., 2021). The peptide isn't named in the abstract, and effect sizes weren't reported.
• Epidermal growth factor (EGF): in a 6-week, placebo-controlled split-face trial of 20 people, inflammatory lesions fell 33.5% on the EGF side while increasing on the control side (Kim et al., 2014). EGF is a protein growth factor rather than a short cosmetic peptide.
• Branded "acne peptides" (e.g., oligopeptide-10): we found no peer-reviewed human trials.

These are early signals, not evidence that a peptide serum will clear breakouts.

Copper peptides and acne scars

Copper peptides (GHK-Cu) are often recommended online for acne scars and post-acne marks. A 2026 systematic review of GHK-Cu with microneedling found the human clinical literature "thin and fragmented," with no adequately powered human trial, and listed acne scarring only as a target for future research (Najafi et al., 2026). We found no clinical trials of copper peptides for acne or acne scars.

For established acne scars, professional treatments (microneedling, lasers, chemical peels, subcision, fillers) have the evidence. For red or brown marks left after breakouts, sun protection, time and ingredients like azelaic acid, retinoids and niacinamide are the usual approaches. More on copper peptides in our GHK-Cu guide.

Where peptides do fit: supporting your acne routine

Acne treatments like benzoyl peroxide and retinoids are effective but often cause dryness, peeling and irritation, a big reason people stop using them. This is where gentle skincare helps:

• Barrier-supporting skincare improves tolerance. In a 12-week double-blind trial, people using adapalene/benzoyl peroxide plus a ceramide cleanser and lotion had lower water loss, less dryness and fewer inflammatory lesions than those using a basic wash (Draelos et al., 2023).
• Moisturizers are recommended alongside acne treatments, and most "acne moisturizers" contain anti-inflammatory and humectant ingredients like glycerin (Chularojanamontri et al., 2014).
• Peptides are gentle signal molecules that fit easily into a lightweight serum or gel-cream, and they won't add the irritation of extra acids. See peptides for sensitive skin.

Niacinamide: the best-supported cosmetic partner

Niacinamide (vitamin B3) has more evidence for acne-prone skin than any peptide:

• In a double-blind trial of 76 people over 8 weeks, 4% niacinamide gel performed comparably to 1% clindamycin, an antibiotic gel (82% vs 68% improved, not a statistically significant difference) (Shalita et al., 1995).
• 2% niacinamide lowered sebum production in a placebo-controlled study of 100 Japanese participants, with mixed results in a Caucasian group (Draelos et al., 2006).

Do peptides cause breakouts?

Peptides themselves aren't known to clog pores, but any product can depending on its overall formula. Also, "non-comedogenic" isn't a standardized test. Research shows that lists of "comedogenic ingredients" from animal models are unreliable, and finished products containing them aren't necessarily pore-clogging (Draelos & DiNardo, 2006). The best test is your own skin: introduce one product at a time.

A sample routine for breakout-prone skin

Morning

1. Gentle cleanser, such as the Green Tea + Cica Gentle Cleanser, or a benzoyl peroxide or salicylic acid wash if your dermatologist recommends it.
2. A lightweight niacinamide or peptide serum, such as the Even Tone Serum (niacinamide + tranexamic acid + ectoin).
3. Oil-free gel-cream: the Cica + Ectoin Comfort Gel Cream.
4. Sunscreen, especially important with retinoids and to help post-acne marks fade.

Evening

1. Gentle cleanse.
2. Your acne treatment (e.g., adapalene, benzoyl peroxide or azelaic acid) as directed.
3. Barrier moisturizer to buffer dryness.

1–2× weekly (if not using a retinoid that night): gentle PHA exfoliation, such as the PHA Gentle Texture Pads.

Our layering guide explains how to combine peptides with retinoids and acids.

Frequently asked questions

Are peptides good for acne?

Peptides aren't a proven acne treatment, and the 2024 American Academy of Dermatology guideline doesn't recommend them. They're gentle and can support a routine built around proven acne treatments by helping skin stay comfortable and hydrated.

Do antimicrobial peptides kill acne bacteria?

Your skin's own antimicrobial peptides help defend against bacteria and rise in acne lesions. Synthetic antimicrobial peptide treatments have worked against acne bacteria in the lab, but haven't shown published benefit in human acne trials yet.

Can copper peptides help acne scars?

There are no clinical trials of copper peptides for acne or acne scars. A 2026 systematic review listed acne scarring as a target for future research. Professional treatments like microneedling, lasers and peels have the best evidence for scars.

Do peptides cause breakouts or purging?

Peptides aren't known to clog pores or cause "purging" (that's typically associated with retinoids and exfoliants). Breakouts from a new product are usually due to the overall formula. Introduce one new product at a time.

Can I use peptides with benzoyl peroxide or retinoids?

Yes. Peptides are generally compatible with acne treatments and can be part of the moisturizing step. Apply your acne treatment as directed, then a peptide serum or moisturizer.

What's better for acne-prone skin, niacinamide or peptides?

Niacinamide has more evidence: in one trial 4% niacinamide performed comparably to an antibiotic gel, and it can reduce oil production. Peptides have only small early studies. Many people use both.

Sources

1. U.S. Code of Federal Regulations. 21 CFR 333.310 — Acne active ingredients. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-333/subpart-D/section-333.310
2. Moradi Tuchayi S, et al. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. https://pubmed.ncbi.nlm.nih.gov/27189872/
3. Reynolds RV, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. https://pubmed.ncbi.nlm.nih.gov/38300170/
4. Liu H, et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev. 2020;5:CD011368. https://pubmed.ncbi.nlm.nih.gov/32356369/
5. Chronnell CM, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001;117(5):1120-1125. https://pubmed.ncbi.nlm.nih.gov/11710922/
6. Nagy I, et al. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 2005;124(5):931-938. https://pubmed.ncbi.nlm.nih.gov/15854033/
7. Ozlu E, et al. Comparison of TLR-2, TLR-4, and antimicrobial peptide levels in different lesions of acne vulgaris. Cutan Ocul Toxicol. 2016;35(4):300-309. https://pubmed.ncbi.nlm.nih.gov/26695933/
8. Lesiak A, et al. Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris. Front Immunol. 2024;15:1502242. https://pubmed.ncbi.nlm.nih.gov/39744637/
9. Harder J, et al. What is the role of antimicrobial peptides (AMP) in acne vulgaris? Exp Dermatol. 2013;22(6):386-391. https://pubmed.ncbi.nlm.nih.gov/23711061/
10. ClinicalTrials.gov. NCT02571998: A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris. https://clinicaltrials.gov/study/NCT02571998
11. ClinicalTrials.gov. NCT02576860: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle (rosacea). https://clinicaltrials.gov/study/NCT02576860
12. ClinicalTrials.gov. NCT02547441: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle (rosacea). https://clinicaltrials.gov/study/NCT02547441
13. Lim HS, et al. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris. Int J Dermatol. 2015;54(7):853-862. https://pubmed.ncbi.nlm.nih.gov/25601314/
14. Woodburn KW, Jaynes J, Clemens LE. Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris. Antibiotics. 2020;9(1):23. https://pubmed.ncbi.nlm.nih.gov/31940992/
15. Lee Y, et al. Topical application of autophagy-activating peptide improved skin barrier function and reduced acne symptoms in acne-prone skin. J Cosmet Dermatol. 2021;20(3):1009-1016. https://pubmed.ncbi.nlm.nih.gov/32697858/
16. Kim HK, et al. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial. Int J Dermatol. 2014;53(8):1031-1036. https://pubmed.ncbi.nlm.nih.gov/24962549/
17. Najafi N, et al. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu in Topical Microneedle Delivery. Arch Intern Med Res. 2026;9(3):269-293. https://pubmed.ncbi.nlm.nih.gov/42787770/
18. Draelos ZD, et al. Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment. J Drugs Dermatol. 2023;22(6):554-558. https://pubmed.ncbi.nlm.nih.gov/37276158/
19. Chularojanamontri L, et al. Moisturizers for Acne: What are their Constituents? J Clin Aesthet Dermatol. 2014;7(5):36-44. https://pubmed.ncbi.nlm.nih.gov/24847408/
20. Shalita AR, et al. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34(6):434-437. https://pubmed.ncbi.nlm.nih.gov/7657446/
21. Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. J Cosmet Laser Ther. 2006;8(2):96-101. https://pubmed.ncbi.nlm.nih.gov/16766489/
22. Draelos ZD, DiNardo JC. A re-evaluation of the comedogenicity concept. J Am Acad Dermatol. 2006;54(3):507-512. https://pubmed.ncbi.nlm.nih.gov/16488305/